Manfred Rüdiger, Ariceum Therapeutics CEO (Presseportal)

Ger­man start­up jumps in­to the hot ra­dio­phar­ma space with a for­mer Ipsen com­pound as lead pro­gram

Ra­dio­phar­ma­ceu­ti­cals are con­tin­u­ing to be­come a hot top­ic in bio­phar­ma, with com­pa­nies such as Se­quoia, No­var­tis and Bris­tol My­ers Squibb look­ing to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.